Stay updated on Advanced Cancers Nivolumab Immuno-therapy Clinical Trial
Sign up to get notified when there's something new on the Advanced Cancers Nivolumab Immuno-therapy Clinical Trial page.

Latest updates to the Advanced Cancers Nivolumab Immuno-therapy Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study record content with a generic error page. This indicates the study details are no longer accessible on the page.SummaryDifference18%

- Check19 days agoChange DetectedThe page's revision label updated from v3.6.6 to v3.7.0, indicating a new version of the study page or its related documentation.SummaryDifference0.0%

- Check33 days agoChange DetectedThe page revision label was updated from v3.6.5 to v3.6.6, indicating a new build of the site. This is a small software update rather than a change to the study information.SummaryDifference0.0%

- Check40 days agoChange DetectedThe study's identifiers now include an NIH grant/contract reference (2016), adding funding attribution to the record for NCT02832167.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5.SummaryDifference0.0%

- Check76 days agoChange DetectedThe revision tag on the page was updated from v3.6.3 to v3.6.4, indicating a small platform version update. There are no apparent changes to study content or visible data beyond the version increase.SummaryDifference0.0%

Stay in the know with updates to Advanced Cancers Nivolumab Immuno-therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Advanced Cancers Nivolumab Immuno-therapy Clinical Trial page.